Contingency Management for Alcohol Use Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-01-31

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Contingency management (CM) treatments are highly efficacious in improving outcomes of substance abusing patients. However, CM has rarely been applied to individuals with alcohol use disorders, primarily because of technological limitations in monitoring drinking. The Secure Continuous Remote Alcohol Monitor (SCRAMx®) is a new technology designed to continuously monitor alcohol consumption 24 hours a day for 7 days per week. The purpose of this study is to evaluate the efficacy of CM in reducing alcohol use using SCRAMx. In total, 120 alcohol abusing or dependent patients initiating outpatient treatment at community-based clinics will be randomly assigned to one of two conditions: standard care, or standard care plus CM with reinforcement based on results of SCRAMx readings. Compared with standard care, it is expected that CM will result in fewer drinking days and longer durations of continuous non-drinking days.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

CM Treatment for Alcohol Dependence Using New Technology

NCT02143037

Alcohol Use Disorder Contingency Management

COMPLETED NA

Remote Monitoring and Contingency Management Reinforcement for Alcohol Abstinence

NCT01307345

Alcohol Use

COMPLETED NA

Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 1

NCT03883126

Alcohol Use Disorder

ACTIVE_NOT_RECRUITING NA

Contingency Management Treatment Duration

NCT00732342

Alcohol Abuse

COMPLETED NA

Contingency Management for Alcohol Use Disorder

NCT03701204

Alcohol Use Disorder

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol Use Disorder Contingency Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

Standard Care

Group Type ACTIVE_COMPARATOR

Standard Care

Intervention Type BEHAVIORAL

Experimental Group

Standard Care plus Prize Contingency Management for Alcohol Abstinence

Group Type EXPERIMENTAL

Prize Contingency Management for Alcohol Abstinence

Intervention Type BEHAVIORAL

The systematic reinforcement of desired behaviors and the withholding of reinforcement for undesired behaviors

Standard Care

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prize Contingency Management for Alcohol Abstinence

The systematic reinforcement of desired behaviors and the withholding of reinforcement for undesired behaviors

Intervention Type BEHAVIORAL

Standard Care

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18 years or older
* current diagnosis of alcohol use disorder and self report of recent alcohol use
* pass an informed consent quiz
* agree to wear a SCRAMx monitor for 12 weeks
* have a standard SCRAMx compatible phone line in their home or agree to attend the clinic weekly for brief research visits/downloads
* agree to sign an off-campus property transfer form and return SCRAMx equipment

Exclusion Criteria

* serious, uncontrolled psychiatric illness
* in recovery from pathological gambling
* have an unstable address
* intend to participate in activities incompatible with SCRAMx over the next 3 months
* are wearing SCRAMx for legal purposes

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No